| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 83926 |
刺五加苷B脂质体,Eleutheroside,B,liposomes,EB-LP |
219 |
axc |
2024-12-20 |
| 83927 |
CAS: 2055024-63-8,NH2-PEG1-Val-Cit-PAB-OH |
172 |
WYQ |
2024-12-20 |
| 83928 |
CH2COOH-PEG3-CH2COOH |
265 |
wyh |
2024-12-20 |
| 83929 |
Fmoc-N-PEG-CH2COOH (MW 5000) |
168 |
h |
2024-12-20 |
| 83930 |
cas:2086689-02-1,2-(Biotin-amido)-1,3-bis(carboxylethoxy)propane,抗体药物偶联物(ADC) |
129 |
kx |
2024-12-20 |
| 83931 |
MAC-VC-PABC-ST7612AA1 |
155 |
zyl |
2024-12-20 |
| 83932 |
CAS: 2055024-57-0,Fmoc-PEG6-Val-Cit-PAB-OH |
147 |
WYQ |
2024-12-20 |
| 83933 |
异戊酰紫草素脂质体,Isovalerylshikonin-liposome,Iso,SHK-lip,定制服务 |
203 |
axc |
2024-12-20 |
| 83934 |
Azido-PEG2-CH2COOH (CHA) |
173 |
h |
2024-12-20 |
| 83935 |
HO-PEG-CH2COOH (MW 3400) |
181 |
h |
2024-12-20 |
| 83936 |
cas:1400191-52-7,DBCO-Sulfo-NHS ester, ADC试剂 |
145 |
kx |
2024-12-20 |
| 83937 |
CAS: 2249935-92-8,Mal-PEG1-Val-Cit-PAB-PNP |
190 |
WYQ |
2024-12-20 |
| 83938 |
MC-Val-Cit-PAB-rifabutin cas:2055900-34-8 |
177 |
zyl |
2024-12-20 |
| 83939 |
Amine-PEG-CH2COOH (MW 3400) |
184 |
h |
2024-12-20 |
| 83940 |
CAS: 2055041-39-7,Mal-PEG4-Val-Cit-PAB-OH |
201 |
WYQ |
2024-12-20 |
| 83941 |
PEG6-(CH2CO2H)2 |
170 |
h |
2024-12-20 |
| 83942 |
cas:173414-89-6,bis(2,5-dioxopyrrolidin-1-yl) 3,3’-(2-((3-(2,5-dioxopyrrolidin-1-yloxy)-3-oxopropoxy)methyl)-2-methylpropane-1,3-diyl)bis(oxy)dipropanoate |
137 |
kx |
2024-12-20 |
| 83943 |
HOOC-PEtOx(50)-Pip,α-羧甲基-聚(2-乙基-2-恶唑啉)-ω-哌啶,HOOC-CH2(C5H9NO)50NC6H12 |
159 |
wyh |
2024-12-20 |
| 83944 |
CAS: 2055041-38-6,Mal-PEG2-Val-Cit-PAB-OH |
163 |
WYQ |
2024-12-20 |
| 83945 |
水杨酸脂质体可溶性微针(SA-LIP-DMNs),定制服务 |
313 |
axc |
2024-12-20 |
| 83946 |
Boc-Aminooxy-PEG4-CH2CO2H |
238 |
h |
2024-12-20 |
| 83947 |
MC-Val-Cit-PAB-Auristatin E cas:2055896-77-8 |
159 |
zyl |
2024-12-20 |
| 83948 |
cas:1245813-70-0,tert-butyl 1-(4-formylphenyl)-1-oxo-5,8,11,14,17,20,23,26,29,32,35-undecaoxa-2-azaheptatriacontan-37-ylcarbamate |
135 |
kx |
2024-12-20 |
| 83949 |
鼠尾草酸脂质体,LP-CA,定制服务 |
193 |
axc |
2024-12-20 |
| 83950 |
Boc-L-Phe(4-CH2-N3)-OH,205127-59-9,Boc-L-苯丙氨酸(4-氨基甲基-叠氮)-羟基 |
146 |
wyh |
2024-12-20 |
| 83951 |
Fmoc-PEG4-Val-Cit-PAB-OH, CAS号:2055024-58-1 |
137 |
WYQ |
2024-12-20 |
| 83952 |
HOOCCH2O-PEG4-CH2COOH |
139 |
h |
2024-12-20 |
| 83953 |
Fmoc-PEG2-Val-Cit-PAB-OH,CAS号:2055024-59-2 |
142 |
WYQ |
2024-12-20 |
| 83954 |
BnO-PEG1-CH2CO2tBu |
475 |
h |
2024-12-20 |
| 83955 |
cas:824426-32-6,Azidoacetic acid NHS ester,叠氮乙酸 NHS 酯, ADC试剂 |
166 |
kx |
2024-12-20 |
| 83956 |
Boc-NH-(CH2)15-COOH , 135747-73-8 |
158 |
wyh |
2024-12-20 |
| 83957 |
Fmoc-PEG3-Val-Cit,N-Fluorenylmethoxycarbonyl-triethylene glycol-Val-Cit |
164 |
WYQ |
2024-12-20 |
| 83958 |
t-Butyl acetate-PEG3-CH2COOH |
160 |
h |
2024-12-20 |
| 83959 |
鼠尾草酸转铁蛋白结合脂质体,Tf-LP-CA,定制服务 |
175 |
axc |
2024-12-20 |
| 83960 |
Cbz-NH-PEG10-CH2COOH |
184 |
h |
2024-12-20 |
| 83961 |
cas:2182601-80-3,Azido-PEG8-CH2CO2-PFP |
162 |
wyh |
2024-12-20 |
| 83962 |
CAS: 2746391-62-6 MAL-di-EG-Val-Cit-PAB-MMAE |
183 |
zyl |
2024-12-20 |
| 83963 |
2,5-dioxopyrrolidin-1-yl 1-(bicyclo[6.1.0]non-4-yn-9-yl)-3-oxo-2,7,10-trioxa-4-azatridecan-13-oate,ADC定制 |
151 |
kx |
2024-12-20 |
| 83964 |
CAS: 2055041-37-5,Mal-PEG1-Val-Cit-PAB-OH |
173 |
WYQ |
2024-12-20 |
| 83965 |
Cbz-NH-PEG8-CH2COOH |
234 |
h |
2024-12-20 |
| 83966 |
CAS: 2055024-60-5,NH2-PEG6-Val-Cit-PAB-OH |
136 |
WYQ |
2024-12-20 |
| 83967 |
苄基-PEG4-乙酸叔丁酯,cas:1443467-88-6,Benzyl-PEG4-CH2CO2tBu |
151 |
wyh |
2024-12-20 |
| 83968 |
Boc-NH-PEG6-CH2COOH |
163 |
h |
2024-12-20 |
| 83969 |
NEs介导的紫杉醇脂质体药物递送系统(NE-LP-PTX),定制服务 |
202 |
axc |
2024-12-20 |
| 83970 |
perfluorophenyl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,抗体药物偶联物(ADC) |
151 |
kx |
2024-12-20 |